Upcoming Financial Results Call for Ardelyx
WALTHAM, Mass. — Ardelyx, Inc. (NASDAQ: ARDX), a prominent biopharmaceutical company dedicated to developing innovative medicines, has announced an upcoming conference call. This important event is scheduled for Thursday, October 31, at 4:30 p.m. Eastern Time. The focus will be on discussing the company's financial results and providing updates on their operations during the third quarter of 2024.
How to Participate in the Conference Call
Interested participants can join the conference call by dialing (877) 346-6112 for domestic calls or (848) 280-6350 for international calls. When calling, simply ask to be connected to the Ardelyx call. The call will also be available via a live audio webcast, which can be accessed on Ardelyx's website under the Investors section. Following the event, an archived version of the webcast will be accessible for 30 days, allowing those who couldn't attend live the opportunity to catch up on the information shared.
Innovative Solutions from Ardelyx
Ardelyx is on a mission to discover, develop, and commercialize cutting-edge medicines that address significant unmet medical needs. The company has successfully launched two key products in the U.S. market: IBSRELA (tenapanor) and XPHOZAH (tenapanor). These products exemplify Ardelyx's commitment to bringing first-in-class solutions to patients.
Global Partnerships for Expanded Reach
Ardelyx has established strategic partnerships to expand the reach of tenapanor beyond the U.S. market. For instance, Kyowa Kirin is responsible for the commercialization of PHOZEVEL (tenapanor) in Japan for hyperphosphatemia, showcasing Ardelyx's commitment to global health. In addition, a New Drug Application for tenapanor targeting hyperphosphatemia has been submitted in China in collaboration with Fosun Pharma, further extending the company's international footprint.
Connecting with Ardelyx
For more detailed information about Ardelyx, interested parties are encouraged to visit their official website. There, they can explore product offerings, recent developments, and overall company performance. Ardelyx also maintains an active presence on various social media platforms, including X (formerly known as Twitter), LinkedIn, and Facebook, providing updates and insights into their ongoing initiatives.
Investor and Media Contacts
For inquiries regarding investments or media relations, interested individuals can reach out to Caitlin Lowie at Ardelyx. She can be contacted via email for further information and assistance.
Frequently Asked Questions
What is the purpose of Ardelyx's upcoming conference call?
The conference call will discuss Ardelyx's financial results for the third quarter of 2024 and provide updates on the company's business operations.
How can I access the conference call?
You can join the call by dialing the provided domestic or international numbers. Additionally, the call will be webcast live through Ardelyx's website.
What products does Ardelyx currently offer?
Ardelyx offers IBSRELA and XPHOZAH, both of which are innovative medicines targeting unmet medical needs.
Are there international partnerships associated with Ardelyx?
Yes, Ardelyx has partnered with Kyowa Kirin for PHOZEVEL's commercialization in Japan and has submitted a drug application for tenapanor in China with Fosun Pharma.
How can I learn more about Ardelyx's products and updates?
Interested parties can visit Ardelyx's official website and follow their social media channels for the latest information and developments.
